If you have been paying attention to the CEO, he has stated they will focus on marketing Tollovid around the holiday season. I think I get the logic behind that decision. If the results of Tollovir are successful, and 3CL protease inhibitors work, it is likely they will be able to market it as an OTC Covid treatment that has an active compound which is much more effective. The trade commission has warned them they cannot market it as such. While I dont believe we will get to $4, it is even more unlikely to do a r/s at $500.